| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $907K | +23.0% |
| Cost of Revenue | $199K | +2.5% |
| Gross Profit | $708K | +30.3% |
| R&D Expense | $215K | +581.4% |
| SG&A Expense | $4.5M | +21.5% |
| Operating Income | -$3.8M | -20.0% |
| Interest Expense | $3.3M | +330.6% |
| Net Income | -$8.5M | -119.0% |
| EPS (Basic) | -$0.24 |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $383K | +44.6% |
| Accounts Receivable | $35K | +98.3% |
| Inventory | $219K | +177.6% |
| Current Assets | $675K | +4.3% |
| Total Assets | $1.4M | -1.1% |
| Current Liabilities | $1.4M | -28.6% |
| Long-term Debt | $672K | -8.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.2M | +10.7% |
| Financing Cash Flow | $1.3M | -18.1% |
| -20.0% |
| EPS (Diluted) | -$0.24 | -20.0% |
| Total Liabilities |
| $2.1M |
| -22.3% |
| Stockholders' Equity | -$723K | +45.2% |